drugset / Trial / NCT02102646
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate if androgen deprivation therapy in men with prostate cancer increases hepatic fat content and changes visceral/subcutaneous fat distribution.
Timeline
- Start
- 2014-04
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Triptorelin | Other / unclassified | 22.5 mg | Intramuscular |